Analysis of the results of non-invasive prenatal testing (NIPT) in 545 pregnant women in advanced maternal age

被引:0
|
作者
Su, J. -Y. [1 ]
Wei, Y. -N. [1 ]
Chen, H. -F. [1 ]
Tong, J. -R. [1 ]
Chen, Y. [1 ]
Deng, L. [1 ]
Huang, L. -L. [1 ]
Zhang, L. -Y. [1 ]
机构
[1] Guangxi Med Univ, Affiliated Hosp 2, Dept Obstet, Nanning, Guangxi, Peoples R China
关键词
Non-invasive prenatal testing; NIPT; Advanced ma-ternal age; Pregnancy; Pregnancy outcomes;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
- OBJECTIVE: This research aimed to explore the value of non-invasive prenatal testing (NIPT) as a prenatal screening method for common aneuploidy in pregnant women in advanced maternal age.PATIENTS AND METHODS: A retrospective analysis was conducted on a cohort of 545 mothers with singleton pregnancy who were of advanced age and underwent NIPT testing voluntarily at the Second Affiliated Hospital of Guangxi Medical University between November 2020 and February 2023. In cases where NIPT testing suggested chromosomal abnormalities, amniocentesis was conducted, karyotype analysis or gene copy number variation (CNV) testing was performed, and the pregnancy outcome was tracked.RESULTS: Among 545 pregnant women in advanced maternal age, 11 cases had high risk of NIPT, and the detection rate was 2.02%. Among 11 pregnant women deemed to be at high risk for NIPT, 10 cases underwent amniotic fluid puncture, and one case refused amniocentesis despite a suggestive chromosomal abnormality in NIPT. The overall rate of amniocentesis was 1.83%. Among 11 pregnant women deemed to be at high risk for NIPT, the results suggested that 5 of them had trisomy 21, 1 had trisomy 18, 2 had sex chromosome abnormalities (specifically, 47, XYY), and 3 had other autosomal abnormalities. The positive predictive values of NIPT were 100.00% for the cases of trisomy 21 and trisomy 18, while the values were 0.00% for the cases of sex chromosome abnormalities and other autosomal abnormalities, respectively. After the follow-up, each of the 6 cases that were diagnosed with definite chromosomal abnormalities during prenatal screening opted to induce labor and terminate the pregnancy, including 5 cases that exhibited a high risk of trisomy 21 (47, XN,+21) and 1 case that showed a high risk of trisomy 18 (47, XN,+18). One instance of NIPT indi cated a potential abnormality in the sex chromosomes, the individual declined to undergo amniocentesis. Another instance of NIPT suggested a sex chromosome abnormality, amniocentesis revealed a deletion of 0.72 Mb in the 4q22.1 region. They all had normal pregnancies and normal newborns. The remaining three cases had normal prenatal diagnoses (46, XN) and experienced normal pregnancies with healthy neonatal outcomes.CONCLUSIONS: NIPT has demonstrated its efficacy as a screening tool in the face of increasing maternal age. As a result, it can substantially decrease the requirement for invasive prenatal diagnosis. Nonetheless, there are instances of erroneous positive outcomes in NIPT testing, and therefore, interventional prenatal diagnosis remains necessary for individuals with high-risk screening outcomes to prevent false positives or unwarranted labor induction.
引用
收藏
页码:7101 / 7106
页数:6
相关论文
共 50 条
  • [31] The value of non-invasive prenatal testing: preferences of Canadian pregnant women, their partners, and health professionals regarding NIPT use and access
    Birko, Stanislav
    Ravitsky, Vardit
    Dupras, Charles
    Le Clerc-Blain, Jessica
    Lemoine, Marie-Eve
    Affdal, Aliya O.
    Haidar, Hazar
    Laberge, Anne-Marie
    BMC PREGNANCY AND CHILDBIRTH, 2019, 19 (1)
  • [32] The value of non-invasive prenatal testing: preferences of Canadian pregnant women, their partners, and health professionals regarding NIPT use and access
    Stanislav Birko
    Vardit Ravitsky
    Charles Dupras
    Jessica Le Clerc-Blain
    Marie-Eve Lemoine
    Aliya O. Affdal
    Hazar Haidar
    Anne-Marie Laberge
    BMC Pregnancy and Childbirth, 19
  • [33] Non-invasive prenatal testing: when results suggests maternal cancer
    Lenaerts, Liesbeth
    Theunis, Miel
    Amant, Frederic
    Vermeesch, Joris R.
    MEDIZINISCHE GENETIK, 2023, 35 (04) : 285 - 295
  • [34] Non-invasive prenatal testing (NIPT): limitations on the way to become diagnosis
    Kotsopoulou, Ioanna
    Tsoplou, Panagiota
    Mavrommatis, Konstantinos
    Kroupis, Christos
    DIAGNOSIS, 2015, 2 (03) : 141 - 158
  • [35] Non-Invasive Prenatal Testing (NIPT): Reliability, Challenges, and Future Directions
    Jayashankar, Siva Shantini
    Nasaruddin, Muhammad Luqman
    Hassan, Muhammad Faiz
    Dasrilsyah, Rima Anggrena
    Shafiee, Mohamad Nasir
    Ismail, Noor Akmal Shareela
    Alias, Ekram
    DIAGNOSTICS, 2023, 13 (15)
  • [36] Regulating non-invasive prenatal testing (NIPT) for fetal sex determination
    Taylor-Sands, Michelle
    Warton, Chanelle
    Bowman-Smart, Hilary
    MEDICAL LAW REVIEW, 2023, 31 (04) : 521 - 537
  • [37] Experience after 3 years of NIPT (Non-Invasive Prenatal Testing)
    Graf, J.
    Benet-Pages, A.
    Mehnert, K.
    Ovens-Raeder, A.
    Schlueter, G.
    Abicht, A.
    Holinski-Feder, E.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 1817 - 1817
  • [38] Quality assurance and standardization in view of non-invasive prenatal testing (NIPT)
    Schenk, Peter W.
    LABORATORIUMSMEDIZIN-JOURNAL OF LABORATORY MEDICINE, 2016, 40 (05): : 307 - 312
  • [39] Non-invasive prenatal testing (NIPT) using maternal plasma DNA: how has it transformed the prenatal screening landscape?
    Bianchi, D. W.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2015, 122 : 368 - 368
  • [40] Adoption of a non-invasive prenatal test (NIPT) in prenatal screening in Moscow: first results
    Olenev, Anton S.
    Baranova, Elena E.
    Sagaydak, Olesya, V
    Galaktionova, Alexandra M.
    Kuznetsova, Ekaterina S.
    Kaplanova, Madina T.
    Belenikin, Maxim S.
    Songolova, Ekaterina N.
    RUSSIAN OPEN MEDICAL JOURNAL, 2021, 10 (01)